JAK3 and acute lymphoblastic leukemia: It is reported that in JAK3 mutation or NOTCH1-induced T-ALL, PHF6 deletion can significantly accelerate the development of the disease, indicating that PHF6 plays a tumor-inhibitory role in T-ALL [20, 21].